Key opportunities in the Global API CDMO Market include expanding pharmaceutical R&D, rising demand for complex therapies, ...

The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by ...

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

Market is projected to expand at a robust CAGR of around 9% over the next five years, driven by the increasing incidence of cancer and chronic diseases, accelerating R&D investments, continuous ...

The Global Active Pharmaceutical Ingredients (API) Market is valued at USD 209.80 Billion in 2024 and is projected to reach a value of USD 445.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the active pharmaceutical ingredients market and it is poised to grow by $ 60.56 bn during 2020-2024, progressing at a CAGR of over 6% during the ...

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Industry in India (2025 - 2030)" report has been added to ResearchAndMarkets.com's offering. In 2023, the active ...

Protein aggregation and active principle ingredients (API) stability are factors that ultimately impact both the usability and quality of many biopharmaceutical products, especially injectables. The ...

India doubles down on domestic active pharmaceutical ingredient manufacturing ...

Researchers from Bochum and Leipzig have successfully used a soil bacterium to specifically produce prodrugs. The key to this step was a detailed understanding of the metabolization of indole. The ...